Cannabics Pharma to provide personalized cannabinoid anti-tumor tests for cancer patients
Cannabics Pharmaceuticals (CNBX) has announced it will begin providing personalized cannabinoid anti-tumor tests for cancer patients.
The diagnostic tests are based on liquid biopsies of patients suffering from any kind of cancer. The test uses CTC technology that collects cancer cells from patients' blood samples, and tests their sensitivity to cannabinoid compounds alongside conventional chemotherapy medicine.............. Source: PharmaBiz
E
Exitable
